Atrial fibrillation is a common arrhythmia encountered in clinical practice. The prevalence
increases with age. A devastating complication of atrial fibrillation is cardioembolic stroke …

Atrial fibrillation (AF) is the most common cardiac arrhythmia and the incidence and
prevalence of this disease are rising. 1 2 It is estimated that by the year 2050 there will be …

Atrial fibrillation (AF) is the most common cardiac arrhythmia in the US Anticoagulation is
recommended for stroke prevention in AF patients with intermediate-to-high stroke risk (ie …

Atrial fibrillation affects approximately 5 million patients in the United States. The rate of
stroke in adults with atrial fibrillation depending on their risk factors varies between 1-20 …

Because atrial fibrillation (AF) is a major risk for thrombotic disease, many patients with AF
are managed with anticoagulation for primary or secondary prevention of these events. The …

The increasing availability of novel oral anticoagulants (NOAC) for the prevention of stroke
and systemic embolism in patients with nonvalvular atrial fibrillation (AF) offers alternatives …

Atrial fibrillation continues to be a significant source of morbidity and mortality worldwide.
Effective anticoagulation remains the cornerstone of outpatient and inpatient treatment. The …

The novel oral anticoagulants (NOACs) have rapidly emerged as an alternative therapy to
warfarin. Several recent phase 3 randomized control trials have demonstrated the efficacy …

Atrial fibrillation (AF) affects about 2% of the population, with the increasing prevalence with
age. It is associated with poorer quality of life, effort intolerance, frequent hospitalizations …

The presence of atrial fibrillation (AF), the most common sustained cardiac arrhythmia,
significantly increases the risk for stroke. Current guidelines recommend that the vitamin K …